JP2023086734A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023086734A5 JP2023086734A5 JP2023051617A JP2023051617A JP2023086734A5 JP 2023086734 A5 JP2023086734 A5 JP 2023086734A5 JP 2023051617 A JP2023051617 A JP 2023051617A JP 2023051617 A JP2023051617 A JP 2023051617A JP 2023086734 A5 JP2023086734 A5 JP 2023086734A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleotide sequence
- composition
- fragment
- sequence identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002773 nucleotide Substances 0.000 claims 30
- 125000003729 nucleotide group Chemical group 0.000 claims 30
- 239000012634 fragment Substances 0.000 claims 26
- 125000003275 alpha amino acid group Chemical group 0.000 claims 13
- 201000010099 disease Diseases 0.000 claims 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 9
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 238000003776 cleavage reaction Methods 0.000 claims 3
- 230000007017 scission Effects 0.000 claims 3
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 208000024908 graft versus host disease Diseases 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 206010057248 Cell death Diseases 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000009089 cytolysis Effects 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 208000021760 high fever Diseases 0.000 claims 1
- 208000015325 multicentric Castleman disease Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025077437A JP2025147175A (ja) | 2016-05-05 | 2025-05-07 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662332377P | 2016-05-05 | 2016-05-05 | |
| US62/332,377 | 2016-05-05 | ||
| JP2019510567A JP7311113B2 (ja) | 2016-05-05 | 2017-05-05 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
| PCT/US2017/031193 WO2017192933A1 (en) | 2016-05-05 | 2017-05-05 | Dna monoclonal antibodies targeting il-6 and cd126 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019510567A Division JP7311113B2 (ja) | 2016-05-05 | 2017-05-05 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025077437A Division JP2025147175A (ja) | 2016-05-05 | 2025-05-07 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023086734A JP2023086734A (ja) | 2023-06-22 |
| JP2023086734A5 true JP2023086734A5 (enExample) | 2023-09-04 |
Family
ID=60203626
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019510567A Active JP7311113B2 (ja) | 2016-05-05 | 2017-05-05 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
| JP2023051617A Pending JP2023086734A (ja) | 2016-05-05 | 2023-03-28 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
| JP2025077437A Pending JP2025147175A (ja) | 2016-05-05 | 2025-05-07 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019510567A Active JP7311113B2 (ja) | 2016-05-05 | 2017-05-05 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025077437A Pending JP2025147175A (ja) | 2016-05-05 | 2025-05-07 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20190192692A1 (enExample) |
| EP (1) | EP3452106A4 (enExample) |
| JP (3) | JP7311113B2 (enExample) |
| KR (3) | KR20250011241A (enExample) |
| CN (1) | CN109789224A (enExample) |
| AU (2) | AU2017261292B2 (enExample) |
| BR (1) | BR112018072697A2 (enExample) |
| CA (1) | CA3023089A1 (enExample) |
| EA (1) | EA201892524A1 (enExample) |
| MX (2) | MX2018013523A (enExample) |
| SG (2) | SG10202011023YA (enExample) |
| WO (1) | WO2017192933A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3534941A4 (en) * | 2016-11-07 | 2020-07-08 | The Wistar Institute Of Anatomy And Biology | CONSTRUCTIONS OF ANTI-DNA ANTIBODIES FOR USE AGAINST LYME DISEASE |
| KR102635888B1 (ko) | 2019-03-19 | 2024-02-15 | 엘지전자 주식회사 | 공기청정기 |
| EP4277929A1 (en) * | 2021-01-14 | 2023-11-22 | Translate Bio, Inc. | Methods and compositions for delivering mrna coded antibodies |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0214168B8 (pt) * | 2001-11-14 | 2021-05-25 | Centocor Inc | anticorpos anti-il-6, moléculas de ácido nucleico codificando os mesmos, vetores compreendendo as referidas moléculas, composições e formulações compreendendo os referidos anticorpos, bem como métodos de produção dos mesmos |
| PA8672101A1 (es) * | 2005-04-29 | 2006-12-07 | Centocor Inc | Anticuerpos anti-il-6, composiciones, métodos y usos |
| CA2632628C (en) * | 2005-12-09 | 2016-01-19 | Ucb Pharma S.A. | Antibody molecules having specificity for human il-6 |
| WO2008019061A2 (en) * | 2006-08-03 | 2008-02-14 | Vaccinex, Inc. | Anti-il-6 monoclonal antibodies and uses thereof |
| JP2011520898A (ja) * | 2008-05-13 | 2011-07-21 | ノビミューン エスアー | 抗ｉｌ−６／ｉｌ−６ｒ抗体およびそれらの使用方法 |
| WO2011084714A2 (en) * | 2009-12-17 | 2011-07-14 | Biogen Idec Ma Inc. | STABILIZED ANTI-TNF-ALPHA scFv MOLECULES OR ANTI-TWEAK scFv MOLECULES AND USES THEREOF |
| US8992908B2 (en) * | 2010-11-23 | 2015-03-31 | Alderbio Holdings Llc | Anti-IL-6 antibodies for the treatment of oral mucositis |
| EP2931318A4 (en) * | 2012-12-13 | 2016-07-20 | Univ Pennsylvania | DNA ANTIBODY CONSTRUCTS AND METHODS FOR USE THEREOF |
| IL312865B2 (en) * | 2013-09-11 | 2025-06-01 | Eagle Biologics Inc | Liquid protein formulations containing viscosity-lowering agents |
| WO2015054293A1 (en) * | 2013-10-07 | 2015-04-16 | Alder Biopharmaceuticals, Inc. | Anti-il-6 antibodies for the treatment of psoriatic arthritis |
-
2017
- 2017-05-05 US US16/098,918 patent/US20190192692A1/en active Pending
- 2017-05-05 AU AU2017261292A patent/AU2017261292B2/en active Active
- 2017-05-05 KR KR1020257000876A patent/KR20250011241A/ko active Pending
- 2017-05-05 JP JP2019510567A patent/JP7311113B2/ja active Active
- 2017-05-05 EP EP17793405.6A patent/EP3452106A4/en active Pending
- 2017-05-05 CN CN201780041454.5A patent/CN109789224A/zh active Pending
- 2017-05-05 SG SG10202011023YA patent/SG10202011023YA/en unknown
- 2017-05-05 SG SG11201809786TA patent/SG11201809786TA/en unknown
- 2017-05-05 WO PCT/US2017/031193 patent/WO2017192933A1/en not_active Ceased
- 2017-05-05 BR BR112018072697-4A patent/BR112018072697A2/pt unknown
- 2017-05-05 CA CA3023089A patent/CA3023089A1/en active Pending
- 2017-05-05 KR KR1020187035166A patent/KR20190031439A/ko not_active Ceased
- 2017-05-05 EA EA201892524A patent/EA201892524A1/ru unknown
- 2017-05-05 MX MX2018013523A patent/MX2018013523A/es unknown
- 2017-05-05 KR KR1020237013950A patent/KR20230058733A/ko not_active Ceased
-
2018
- 2018-11-05 MX MX2025009846A patent/MX2025009846A/es unknown
-
2023
- 2023-03-28 JP JP2023051617A patent/JP2023086734A/ja active Pending
-
2024
- 2024-05-10 AU AU2024203109A patent/AU2024203109B2/en active Active
-
2025
- 2025-05-07 JP JP2025077437A patent/JP2025147175A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022105138A5 (enExample) | ||
| JP2022553324A5 (enExample) | ||
| JP2019522490A5 (enExample) | ||
| CY1118037T1 (el) | Αντισωματα εναντι του αβητα και h χρηση τους | |
| JP2021524270A5 (enExample) | ||
| JP2020517635A5 (enExample) | ||
| RU2012118636A (ru) | Молекула, специфически связывающаяся с rsv | |
| JP2010512792A5 (enExample) | ||
| JP2021524275A5 (enExample) | ||
| MX347175B (es) | Anticuerpos igm humanos con la capacidad de inducir remielinacion, y usos diagnosticos y terapeuticos de los mismos particularmente en el sistema nervioso central. | |
| EA199800046A1 (ru) | Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента | |
| CN112851805B (zh) | 一种结合血清白蛋白的蛋白及其用途 | |
| JP2022542670A5 (enExample) | ||
| JP2023171909A5 (enExample) | ||
| JP2023530663A5 (enExample) | ||
| JP2022512650A5 (enExample) | ||
| JP2020518249A5 (enExample) | ||
| RU2002133470A (ru) | Специфичные в отношении вируса бешенства нейтрализующие моноклональные антитела человека и нуклеиновые кислоты, и связанные с ними способы | |
| WO2023009028A1 (ru) | Однодоменное антитело и его модификации, специфически связывающиеся с rbd s белка вируса sars-cov-2 | |
| RU2004108115A (ru) | Рекомбинантные антитела и композиции, а также способы их создания и использования | |
| Kalinke et al. | Monovalent single‐chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection | |
| CA2539172C (fr) | Procede a haut rendement pour l'obtention d'anticorps humains neutralisant l'activite biologique d'une cytokine humaine | |
| RU2020115161A (ru) | Днк моноклональных антител против ctla-4 для лечения и профилактики рака | |
| JP2022517865A5 (enExample) | ||
| JP2024529044A5 (enExample) |